BioEmu · azureml v4 ↗
- source model id
- azureml/BioEmu@4
- hosting
- foundry-managed-compute
- platforms
- Microsoft Foundry
- license
- MIT
- max output tokens
- 4096
- architecture
- input_modalities
- text
- output_modalities
- text
- capabilities
# Key capabilities ## About this model The BioEmu model is intended for prediction of protein equilibrium structure ensembles. The model is used for predicting diverse protein structures that emulate…
azureFoundry/azureml/BioEmu@4
The BioEmu model is intended for prediction of protein equilibrium structure ensembles. The model is used for predicting diverse protein structures that emulate the thermodynamic ensemble (i.e., Boltzmann distribution) given an amino acid sequence. An interface to side-chain reconstruction and MD equilibration is provided.
See Responsible AI for additional considerations for responsible use.
The model is used for predicting diverse protein structures that emulate the thermodynamic ensemble (i.e., Boltzmann distribution) given an amino acid sequence. Examples of direct usages include but not limited to prediction of structural ensembles, prediction of folding free energies, providing mechanistic hypotheses. The model is intended for research and experimental purposes.
The model only supports predictions of protein structures in backbone frame representation. Any attempt and interpretation beyond that should be avoided. The model does not support generation of new protein sequences as it is designed for the above purpose only. The current model has low prediction quality for protein-protein interactions, including multi-chain proteins, and does not feature explicit interactions with other chemical entities like small molecules. Further testing/development are needed before considering its application in real-world scenarios. We advice against predicting entities that are not considered by the used embeddings or represented in the training data, including but not limited to multi-chain proteins.
Pricing is based on a number of factors, including deployment type and tokens used. See pricing details here.
Developed by: Sarah Lewis, Tim Hempel, José Jiménez-Luna, Michael Gastegger, Yu Xie, Andrew Y. K. Foong, Victor García Satorras, Osama Abdin, Bastiaan S. Veeling, Iryna Zaporozhets, Yaoyi Chen, Soojung Yang, Adam Foster, Arne Schneuing, Jigyasa Nigam, Federico Barbero, Vincent Stimper, Andrew Campbell, Jason Yim, Marten Lienen, Yu Shi, Shuxin Zheng, Hannes Schulz, Usman Munir, Roberto Sordillo, Ryota Tomioka, Cecilia Clementi, Frank Noé
Model type: We only release the model fine-tuned with amber data (BioEmu 1.1).
Model Parameters: 31M
Training Data Size: 161k structures (AFDB), 216 ms MD simulations, 502k dG measurements
The provider has not supplied this information.
The provider has not supplied this information.
{
"input_data":
{
"sequence": "GYDPETGTWG",
"num_samples": 10
}
}
{
"status": "success",
"results":
{
"sequence.fasta": "<binary file content>",
"topology.pdb": "<binary file content>",
"samples.xtc": "<binary file content>"
}
}
The provider has not supplied this information.
{
"status": "success",
"results":
{
"sequence.fasta": "<binary file content>",
"topology.pdb": "<binary file content>",
"samples.xtc": "<binary file content>"
}
}
BioEmu-v1 model is DiG architecture (https://www.nature.com/articles/s42256-024-00837-3) trained on a variety of datasets to sample systematically diverse structure ensembles. In the pretraining phase, we use denoising score matching to match the distribution of flexible protein structures curated from AFDB. In the fine-tuning phase, we use a combination of denoising score matching objective for molecular dynamics data and property prediction fine-tuning (PPFT) for matching the experimental folding free energies.
The provider has not supplied this information.
The provider has not supplied this information.
Our model has been trained on a large variety of structurally resolved proteins, so it inherits the biases of this data. Besides experimental data, the model is trained on synthetic data, which is predictions of AlphaFold2 and molecular dynamics simulations. We expect that the approximations of these models are propagated to BioEmu. For testing conformational changes, sets of structures exhibiting different phenomena (local unfolding, domain motion and formation of cryptic pockets) were curated based on PDB reports and published literature. To test emulation of MD equilibrium distributions, an in-house dataset of molecular dynamics simulation based on the CATH classification of proteins was generated. Protein stability predictions were evaluated using a combination of published experimental folding free energies.
The provider has not supplied this information.
Please refer to the BioEmu manuscript for more details on the model.
License: MIT License
Funded by: Microsoft Research AI for Science
1–1 / 1
1–1 / 1
1–3 / 3
Microsoft Foundry · Model page ↗
1–1 / 1
These charts contain model-linked results. The charts above also include unlinked source profiles. Compare scores within each evaluation. Model quality, usage, transparency and system performance measure different things.